tm logo

Monitor this mark

View On USPTO

CEAVADCI
Live/Registered
REGISTERED

on 11 Jun 2024

Last Applicant/ Owned by

Sanofi

46 avenue de la Grande Armée

Paris

FR

75017

Serial Number

97706680 filed on 07th Dec 2022

Registration Number

7411414 registered on 11th Jun 2024

in the Principal Register

Correspondent Address

NEW YORK, NY 10036

UNITED STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

CEAVADCI

Pharmaceutical preparations for the treatment of inflammation, cancer, multiple sclerosis, and autoimmune, inflammatory, and blood diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of inflammation, cancer, multiple sclerosis, and autoimmune, inflammatory, and blood diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97706680

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SYN 2224069

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
11th Jun 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
11th Jun 2024REGISTERED-PRINCIPAL REGISTER
26th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26th Mar 2024PUBLISHED FOR OPPOSITION
06th Mar 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21st Feb 2024APPROVED FOR PUB - PRINCIPAL REGISTER
20th Feb 2024TEAS/EMAIL CORRESPONDENCE ENTERED
20th Feb 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
20th Feb 2024ASSIGNED TO LIE